Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Cole

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|October 4, 2000
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposisR F Jacoby, K Seibert, C E Cole, et al.
Gastroenterology|April 1, 1997
A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propriaR F Jacoby, S Schlack, C E Cole, et al.
Cancer Research|April 15, 2000
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryosR F Jacoby, C E Cole, K Tutsch, et al.
Journal of Virology|September 11, 1999
CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoirS Moir, R Lapointe, A Malaspina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiersR B Halberg, D S Katzung, P D Hoff, et al.
Genomics|September 2, 1998
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancerK A Cole, R F Chuaqui, K Katz, et al.
Cancer Research|February 15, 1996
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicamR F Jacoby, D J Marshall, M A Newton, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|October 4, 2000
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposisR F Jacoby, K Seibert, C E Cole, et al.
Gastroenterology|April 1, 1997
A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propriaR F Jacoby, S Schlack, C E Cole, et al.
Cancer Research|April 15, 2000
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryosR F Jacoby, C E Cole, K Tutsch, et al.
Journal of Virology|September 11, 1999
CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoirS Moir, R Lapointe, A Malaspina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2000
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiersR B Halberg, D S Katzung, P D Hoff, et al.
Genomics|September 2, 1998
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancerK A Cole, R F Chuaqui, K Katz, et al.
Cancer Research|February 15, 1996
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicamR F Jacoby, D J Marshall, M A Newton, et al.
Pageof 2